The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

MreB, a novel target to inhibit bacterial growth

Researchers at Stanford University and the Tokyo Institute of Technology identified a novel anti-bacterial protein target along with a small molecule with the potential to become a novel antibiotic agent. The target, MreB, is a cytoskeletal protein that ...
more information »

Chloroquine enantiomer to treat tuberculosis

Dr. Jeffery Glenn and colleagues have identified a specific chloroquine enantiomer that may be used to treat tuberculosis (TB). TB is caused by Mycobacterium tuberculosis, which most often affects the lungs. It is a significant cause of morbidity ...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.